FRZB and pancreatic neoplasm: The present investigation was designed to determine whether the four cardiac hormones inhibit sFRP-3 in human renal carcinoma, human pancreatic cancer and human colorectal cancer cells as part of their anti-cancer mechanism(s) of action.